Table 2 Study calendar
Intervention components | Intervention Group | Control Group |
|---|---|---|
Information about the study (oral and written formats) | x | x |
Informed consent | x | x |
Enrolment in the study | x | x |
Clinical and socio-demographic data collection | x | x |
ePROs collected at baseline and end-of-study | x | x |
A baseline clinic visit involving: | ||
- one-on-one consultation with the study nurse | x | x |
- one-to-one consultation with the study dietitian and conduct of dietary and body composition assessments | x | x |
- a study resource folder containing “Survivorship Personal Treatment Care Plan” and recommended support resources about survivorship | x | x |
- an “Education and Symptom Management Pathway” | x | |
- “Personalized Nutrition Care Plans” containing diet education and nutritional counselling for participants at nutritional risk | x | |
Ongoing monitoring of cancer related symptoms collected via ePRO symptom questionnaires at 2, 4, 6, 8, and 10 months | x | |
Access to a trigger-initiated symptom management pathway(s) or a six-monthly follow-up phone call with the study’s nurse (if no triggers) | x | |
Ongoing monitoring of weight, physical activity and changes in nutritional risk collected via ePRO symptom questionnaires at 2, 4, 6, 8, and 10 months | x | |
Access to a trigger-initiated nutritional management pathway | x | |
End of study clinic visit involving: | ||
- one-on-one consultation with the study nurse | x | x |
- one-to-one consultation with the study dietitian and repeat dietary and body composition assessments | x | x |
Feasibility process evaluation surveys, and interviews or focus groups (post-intervention) | x | x |
Measurement of resource utilization | x | x |